Platelet GPIbα is a mediator and potential interventional target for NASH and subsequent liver cancer (original) (raw)

Dissociating nonalcoholic steatohepatitis from hepatocellular carcinoma in obesity

Paraskevi Papaioannidou

Hepatobiliary Surgery and Nutrition

View PDFchevron_right

Mechanisms that associate extension of Nonalcoholic fatty liver diseases(NAFLD) to NASH (Nonalcoholic steatohepatitis) and further progressing to cirrhosis and Hepatocellular carcinoma(HCC) in addition to few proposed biomarkers for poor prognosis

Kulvinder K O C H A R Kaur

Mechanisms that associate extension of Nonalcoholic fatty liver diseases(NAFLD) to NASH (Nonalcoholic steatohepatitis) and further progressing to cirrhosis and Hepatocellular carcinoma(HCC) in addition to few proposed biomarkers for poor prognosis, 2021

View PDFchevron_right

Cardiovascular and Systemic Risk in Nonalcoholic Fatty Liver Disease - Atherosclerosis as a Major Player in the Natural Course of NAFLD

Giovanni Targher

Current Pharmaceutical Design, 2013

View PDFchevron_right

Hepatocellular carcinoma in non-alcoholic fatty liver disease: An emerging menace

Luca Valenti

Journal of Hepatology, 2012

View PDFchevron_right

Challenges and Solutions in the Management of Hepatocellular Carcinoma Associated with Non-Alcoholic Fatty Liver Disease

Corina Ursulescu

View PDFchevron_right

The riddle of Nonalcoholic fatty liver disease: Progression from NAFL to NASH

Rathindra Mukherjee

Journal of Clinical and Experimental Hepatology, 2015

View PDFchevron_right

The OMICs Window into Nonalcoholic Fatty Liver Disease (NAFLD)

Lucia CARULLI

Metabolites, 2019

View PDFchevron_right

Current and Future Therapeutic Regimens for Non-alcoholic Fatty Liver Disease (NAFLD) and Non-alcoholic Steatohepatitis (NASH)

Scott Friedman

Hepatology (Baltimore, Md.), 2017

View PDFchevron_right

Hepatocellular carcinoma in the context of non-alcoholic steatohepatitis (NASH): recent advances in the pathogenic mechanisms

Jean-pierre Couty

Hormone Molecular Biology and Clinical Investigation, 2020

View PDFchevron_right

Nonalcoholic Fatty Liver Disease (NAFLD) - A Disease of New Era

Tak Mahmood

Journal of Medicine, 1970

View PDFchevron_right

A Review Of Current And Upcoming Treatment Modalities In Non-Alcoholic Fatty Liver Disease And Non-Alcoholic Steatohepatitis

Peter DeLeeuw

Hepatic Medicine: Evidence and Research

View PDFchevron_right

Aisf Position Paper on Nonalcoholic Fatty Liver Disease (Nafld): Updates and Future Directions

Stefano Bellentani

Digestive and Liver Disease, 2017

View PDFchevron_right

REVIEW ARTICLE NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) - A DISEASE OF NEW ERA

hanif mohammad

2007

View PDFchevron_right

Non-alcoholic fatty liver disease (nafld) - a novel common aspect of the metabolic syndrome

Giulio Marchesini

Biomedical Papers, 2006

View PDFchevron_right

Emerging risk factors for nonalcoholic fatty liver disease associated hepatocellular carcinoma

Jihane Benhammou, Mohamed El-Kabany, Hepatoma Research

Hepatoma Research, 2020

View PDFchevron_right

Non-Alcoholic Fatty Liver Disease – A Brief Insight into Pathogenesis and Review of Recent Reports on Therapeutic Targets

Chinnasamy Thirunavukkarasu

2015

View PDFchevron_right

Underrated enemy - from nonalcoholic fatty liver disease to cancers of the gastrointestinal tract

Tomasz Menżyk

Clinical and experimental hepatology, 2018

View PDFchevron_right

Nonalcoholic steatohepatitis: emerging targeted therapies to optimize treatment options

Sandra Milić

Drug Design, Development and Therapy, 2015

View PDFchevron_right

Non-alcoholic fatty liver disease: An under-recognized cause with emerging importance

Dr. Subir Kumar Das

Current Science, 2006

View PDFchevron_right

Current treatment paradigms and emerging therapies for NAFLD/NASH

Aditya Upadhyay

Frontiers in Bioscience, 2021

View PDFchevron_right

Translational approaches: from fatty liver to non-alcoholic steatohepatitis

Stefano Bellentani

World journal of gastroenterology : WJG, 2014

View PDFchevron_right

Non-alcoholic Fatty Liver Disease: Growing Burden, Adverse Outcomes and Associations

Dr Rajeev Nayan Priyadarshi

Journal of Clinical and Translational Hepatology, 2019

View PDFchevron_right

Fatty Liver and Hepatocellular Carcinoma

Giorgio Bedogni

2020

View PDFchevron_right